APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Rheumatoid Arthritis Stem Cell Therapy

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Rheumatoid Arthritis Stem Cell Therapy Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Report ID 174032790320 December 2025189 pages

Choose your research edition.

Industry ResearchRheumatoid Arthritis Stem Cell Therapy Industry Research Report 2026119 pages · $2,950 USDIndustry Growth & TrendsGlobal Rheumatoid Arthritis Stem Cell Therapy Industry Growth and Trends Forecast to 203287 pages · $3,450 USDMarket StructureGlobal Rheumatoid Arthritis Stem Cell Therapy Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032189 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Rheumatoid Arthritis Stem Cell Therapy Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Rheumatoid Arthritis Stem Cell Therapy Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Rheumatoid Arthritis Stem Cell Therapy market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Rheumatoid Arthritis Stem Cell Therapy is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Rheumatoid Arthritis Stem Cell Therapy is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Rheumatoid Arthritis Stem Cell Therapy is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Rheumatoid Arthritis Stem Cell Therapy is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Rheumatoid Arthritis Stem Cell Therapy include International Stem Cell Corporation, Mesoblast, Regeneus, ReNeuron Group, Roslin Cells and Takeda, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Rheumatoid Arthritis Stem Cell Therapy market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Rheumatoid Arthritis Stem Cell Therapy and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Rheumatoid Arthritis Stem Cell Therapy revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Rheumatoid Arthritis Stem Cell Therapy market size, projected growth trends, production technologies, key applications, and end-use industries.

Rheumatoid Arthritis Stem Cell Therapy Segment by Company

International Stem Cell Corporation

Mesoblast

Regeneus

ReNeuron Group

Roslin Cells

Takeda

Rheumatoid Arthritis Stem Cell Therapy Segment by Type

Adipose Tissue Stem Cells

Allogeneic Mesenchymal Stem Cells

Bone Marrow Transplant

Rheumatoid Arthritis Stem Cell Therapy Segment by Application

Ambulatory Surgical Centers

Hospitals

Specialty Clinics

Rheumatoid Arthritis Stem Cell Therapy Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Rheumatoid Arthritis Stem Cell Therapy market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Rheumatoid Arthritis Stem Cell Therapy and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Rheumatoid Arthritis Stem Cell Therapy.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Rheumatoid Arthritis Stem Cell Therapy in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Rheumatoid Arthritis Stem Cell Therapy industry.

Chapter 3: Detailed analysis of Rheumatoid Arthritis Stem Cell Therapy companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Rheumatoid Arthritis Stem Cell Therapyrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Rheumatoid Arthritis Stem Cell Therapy Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Adipose Tissue Stem Cells Table 3. Key Players of Allogeneic Mesenchymal Stem Cells Table 4. Key Players of Bone Marrow Transplant Table 4. Global Rheumatoid Arthritis Stem Cell Therapy Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Ambulatory Surgical Centers Table 6. Key Players of Hospitals Table 7. Key Players of Specialty Clinics Table 8. Global Rheumatoid Arthritis Stem Cell Therapy Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 9. Global Rheumatoid Arthritis Stem Cell Therapy Market Size by Region (2021-2026) & (US$ Million) Table 10. Global Rheumatoid Arthritis Stem Cell Therapy Market Share by Region (2021-2026) Table 11. Global Rheumatoid Arthritis Stem Cell Therapy Market Size by Region (2027-2032) & (US$ Million) Table 12. Global Rheumatoid Arthritis Stem Cell Therapy Market Share by Region (2027-2032) Table 13. Rheumatoid Arthritis Stem Cell Therapy Industry Trends Table 14. Rheumatoid Arthritis Stem Cell Therapy Industry Drivers Table 15. Rheumatoid Arthritis Stem Cell Therapy Industry Opportunities and Challenges Table 16. Rheumatoid Arthritis Stem Cell Therapy Industry Restraints Table 17. Global Rheumatoid Arthritis Stem Cell Therapy Revenue by Company (US$ Million) & (2021-2026) Table 18. Global Rheumatoid Arthritis Stem Cell Therapy Revenue Market Share by Company (2021-2026) Table 19. Global Rheumatoid Arthritis Stem Cell Therapy Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 20. Global Rheumatoid Arthritis Stem Cell Therapy Key Company Head Office and Area Served Table 21. Global Rheumatoid Arthritis Stem Cell Therapy Company, Product Type & Application Table 22. Global Rheumatoid Arthritis Stem Cell Therapy Company Establishment Date Table 23. Global Company Market Concentration Ratio (CR5 and HHI) Table 24. Global Rheumatoid Arthritis Stem Cell Therapy by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 25. Global Rheumatoid Arthritis Stem Cell Therapy Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Rheumatoid Arthritis Stem Cell Therapy Market Size by Type (2021-2026) & (US$ Million) Table 27. Global Rheumatoid Arthritis Stem Cell Therapy Market Size by Type (2027-2032) & (US$ Million) Table 28. Global Rheumatoid Arthritis Stem Cell Therapy Revenue Market Share by Type (2021-2026) Table 29. Global Rheumatoid Arthritis Stem Cell Therapy Revenue Market Share by Type (2027-2032) Table 30. Global Rheumatoid Arthritis Stem Cell Therapy Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Rheumatoid Arthritis Stem Cell Therapy Market Size by Application (2021-2026) & (US$ Million) Table 32. Global Rheumatoid Arthritis Stem Cell Therapy Market Size by Application (2027-2032) & (US$ Million) Table 33. Global Rheumatoid Arthritis Stem Cell Therapy Revenue Market Share by Application (2021-2026) Table 34. Global Rheumatoid Arthritis Stem Cell Therapy Revenue Market Share by Application (2027-2032) Table 35. International Stem Cell Corporation Company Information Table 36. International Stem Cell Corporation Business Overview Table 37. International Stem Cell Corporation Rheumatoid Arthritis Stem Cell Therapy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 38. International Stem Cell Corporation Rheumatoid Arthritis Stem Cell Therapy Product Portfolio Table 39. International Stem Cell Corporation Recent Development Table 40. Mesoblast Company Information Table 41. Mesoblast Business Overview Table 42. Mesoblast Rheumatoid Arthritis Stem Cell Therapy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. Mesoblast Rheumatoid Arthritis Stem Cell Therapy Product Portfolio Table 44. Mesoblast Recent Development Table 45. Regeneus Company Information Table 46. Regeneus Business Overview Table 47. Regeneus Rheumatoid Arthritis Stem Cell Therapy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. Regeneus Rheumatoid Arthritis Stem Cell Therapy Product Portfolio Table 49. Regeneus Recent Development Table 50. ReNeuron Group Company Information Table 51. ReNeuron Group Business Overview Table 52. ReNeuron Group Rheumatoid Arthritis Stem Cell Therapy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. ReNeuron Group Rheumatoid Arthritis Stem Cell Therapy Product Portfolio Table 54. ReNeuron Group Recent Development Table 55. Roslin Cells Company Information Table 56. Roslin Cells Business Overview Table 57. Roslin Cells Rheumatoid Arthritis Stem Cell Therapy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. Roslin Cells Rheumatoid Arthritis Stem Cell Therapy Product Portfolio Table 59. Roslin Cells Recent Development Table 60. Takeda Company Information Table 61. Takeda Business Overview Table 62. Takeda Rheumatoid Arthritis Stem Cell Therapy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 63. Takeda Rheumatoid Arthritis Stem Cell Therapy Product Portfolio Table 64. Takeda Recent Development Table 65. North America Rheumatoid Arthritis Stem Cell Therapy Market Size by Type (2021-2026) & (US$ Million) Table 66. North America Rheumatoid Arthritis Stem Cell Therapy Market Size by Type (2027-2032) & (US$ Million) Table 67. North America Rheumatoid Arthritis Stem Cell Therapy Market Size by Application (2021-2026) & (US$ Million) Table 68. North America Rheumatoid Arthritis Stem Cell Therapy Market Size by Application (2027-2032) & (US$ Million) Table 69. North America Rheumatoid Arthritis Stem Cell Therapy Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 70. North America Rheumatoid Arthritis Stem Cell Therapy Market Size by Country (2021-2026) Table 71. North America Rheumatoid Arthritis Stem Cell Therapy Market Size by Country (2027-2032) Table 72. Europe Rheumatoid Arthritis Stem Cell Therapy Market Size by Type (2021-2026) & (US$ Million) Table 73. Europe Rheumatoid Arthritis Stem Cell Therapy Market Size by Type (2027-2032) & (US$ Million) Table 74. Europe Rheumatoid Arthritis Stem Cell Therapy Market Size by Application (2021-2026) & (US$ Million) Table 75. Europe Rheumatoid Arthritis Stem Cell Therapy Market Size by Application (2027-2032) & (US$ Million) Table 76. Europe Rheumatoid Arthritis Stem Cell Therapy Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 77. Europe Rheumatoid Arthritis Stem Cell Therapy Market Size by Country (2021-2026) Table 78. Europe Rheumatoid Arthritis Stem Cell Therapy Market Size by Country (2027-2032) Table 79. China Rheumatoid Arthritis Stem Cell Therapy Market Size by Type (2021-2026) & (US$ Million) Table 80. China Rheumatoid Arthritis Stem Cell Therapy Market Size by Type (2027-2032) & (US$ Million) Table 81. China Rheumatoid Arthritis Stem Cell Therapy Market Size by Application (2021-2026) & (US$ Million) Table 82. China Rheumatoid Arthritis Stem Cell Therapy Market Size by Application (2027-2032) & (US$ Million) Table 83. Asia Rheumatoid Arthritis Stem Cell Therapy Market Size by Type (2021-2026) & (US$ Million) Table 84. Asia Rheumatoid Arthritis Stem Cell Therapy Market Size by Type (2027-2032) & (US$ Million) Table 85. Asia Rheumatoid Arthritis Stem Cell Therapy Market Size by Application (2021-2026) & (US$ Million) Table 86. Asia Rheumatoid Arthritis Stem Cell Therapy Market Size by Application (2027-2032) & (US$ Million) Table 87. Asia Rheumatoid Arthritis Stem Cell Therapy Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 88. Asia Rheumatoid Arthritis Stem Cell Therapy Market Size by Country (2021-2026) Table 89. Asia Rheumatoid Arthritis Stem Cell Therapy Market Size by Country (2027-2032) Table 90. South America, Middle East & Africa Rheumatoid Arthritis Stem Cell Therapy Market Size by Type (2021-2026) & (US$ Million) Table 91. South America, Middle East & Africa Rheumatoid Arthritis Stem Cell Therapy Market Size by Type (2027-2032) & (US$ Million) Table 92. South America, Middle East & Africa Rheumatoid Arthritis Stem Cell Therapy Market Size by Application (2021-2026) & (US$ Million) Table 93. South America, Middle East & Africa Rheumatoid Arthritis Stem Cell Therapy Market Size by Application (2027-2032) & (US$ Million) Table 94. South America, Middle East & Africa Rheumatoid Arthritis Stem Cell Therapy Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 95. South America, Middle East & Africa Rheumatoid Arthritis Stem Cell Therapy Market Size by Country (2021-2026) Table 96. South America, Middle East & Africa Rheumatoid Arthritis Stem Cell Therapy Market Size by Country (2027-2032) Table 97. Research Programs/Design for This Report Table 98. Authors List of This Report Table 99. Secondary Sources Table 100. Primary Sources List of Figures Figure 1. Rheumatoid Arthritis Stem Cell Therapy Product Image Figure 2. Global Rheumatoid Arthritis Stem Cell Therapy Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Rheumatoid Arthritis Stem Cell Therapy Market Share by Type: 2025 VS 2032 Figure 4. Adipose Tissue Stem Cells Image Figure 5. Allogeneic Mesenchymal Stem Cells Image Figure 6. Bone Marrow Transplant Image Figure 7. Global Rheumatoid Arthritis Stem Cell Therapy Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 8. Global Rheumatoid Arthritis Stem Cell Therapy Market Share by Application: 2025 VS 2032 Figure 9. Ambulatory Surgical Centers Image Figure 10. Hospitals Image Figure 11. Specialty Clinics Image Figure 12. Global Rheumatoid Arthritis Stem Cell Therapy Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Rheumatoid Arthritis Stem Cell Therapy Market Size (2021-2032) & (US$ Million) Figure 14. Global Rheumatoid Arthritis Stem Cell Therapy Market Share by Region: 2025 VS 2032 Figure 15. Years Considered Figure 16. Global Rheumatoid Arthritis Stem Cell Therapy Market Share by Players in 2025 Figure 17. Global Top 5 and 10 Rheumatoid Arthritis Stem Cell Therapy Players Market Share by Revenue in 2025 Figure 18. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 19. Global Rheumatoid Arthritis Stem Cell Therapy Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Rheumatoid Arthritis Stem Cell Therapy Revenue Market Share by Type (2021-2032) Figure 21. Global Rheumatoid Arthritis Stem Cell Therapy Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global Rheumatoid Arthritis Stem Cell Therapy Revenue Market Share by Application (2021-2032) Figure 23. North America Rheumatoid Arthritis Stem Cell Therapy Market Size (2021-2032) & (US$ Million) Figure 24. North America Rheumatoid Arthritis Stem Cell Therapy Market Share by Type (2021-2032) Figure 25. North America Rheumatoid Arthritis Stem Cell Therapy Market Share by Application (2021-2032) Figure 26. North America Rheumatoid Arthritis Stem Cell Therapy Market Share by Country (2021-2032) Figure 27. United States Rheumatoid Arthritis Stem Cell Therapy Market Size (2021-2032) & (US$ Million) Figure 28. Canada Rheumatoid Arthritis Stem Cell Therapy Market Size (2021-2032) & (US$ Million) Figure 29. Mexico Rheumatoid Arthritis Stem Cell Therapy Market Size (2021-2032) & (US$ Million) Figure 30. Europe Rheumatoid Arthritis Stem Cell Therapy Market Size (2021-2032) & (US$ Million) Figure 31. Europe Rheumatoid Arthritis Stem Cell Therapy Market Share by Type (2021-2032) Figure 32. Europe Rheumatoid Arthritis Stem Cell Therapy Market Share by Application (2021-2032) Figure 33. Europe Rheumatoid Arthritis Stem Cell Therapy Market Share by Country (2021-2032) Figure 34. Germany Rheumatoid Arthritis Stem Cell Therapy Market Size (2021-2032) & (US$ Million) Figure 35. France Rheumatoid Arthritis Stem Cell Therapy Market Size (2021-2032) & (US$ Million) Figure 36. U.K. Rheumatoid Arthritis Stem Cell Therapy Market Size (2021-2032) & (US$ Million) Figure 37. Italy Rheumatoid Arthritis Stem Cell Therapy Market Size (2021-2032) & (US$ Million) Figure 38. Russia Rheumatoid Arthritis Stem Cell Therapy Market Size (2021-2032) & (US$ Million) Figure 39. Nordic Countries Rheumatoid Arthritis Stem Cell Therapy Market Size (2021-2032) & (US$ Million) Figure 40. China Rheumatoid Arthritis Stem Cell Therapy Market Size (2021-2032) & (US$ Million) Figure 41. China Rheumatoid Arthritis Stem Cell Therapy Market Share by Type (2021-2032) Figure 42. China Rheumatoid Arthritis Stem Cell Therapy Market Share by Application (2021-2032) Figure 43. Asia Rheumatoid Arthritis Stem Cell Therapy Market Size (2021-2032) & (US$ Million) Figure 44. Asia Rheumatoid Arthritis Stem Cell Therapy Market Share by Type (2021-2032) Figure 45. Asia Rheumatoid Arthritis Stem Cell Therapy Market Share by Application (2021-2032) Figure 46. Asia Rheumatoid Arthritis Stem Cell Therapy Market Share by Country (2021-2032) Figure 47. Japan Rheumatoid Arthritis Stem Cell Therapy Market Size (2021-2032) & (US$ Million) Figure 48. South Korea Rheumatoid Arthritis Stem Cell Therapy Market Size (2021-2032) & (US$ Million) Figure 49. Taiwan Rheumatoid Arthritis Stem Cell Therapy Market Size (2021-2032) & (US$ Million) Figure 50. Southeast Asia Rheumatoid Arthritis Stem Cell Therapy Market Size (2021-2032) & (US$ Million) Figure 51. India Rheumatoid Arthritis Stem Cell Therapy Market Size (2021-2032) & (US$ Million) Figure 52. Australia Rheumatoid Arthritis Stem Cell Therapy Market Size (2021-2032) & (US$ Million) Figure 53. South America, Middle East & Africa Rheumatoid Arthritis Stem Cell Therapy Market Size (2021-2032) & (US$ Million) Figure 54. South America, Middle East & Africa Rheumatoid Arthritis Stem Cell Therapy Market Share by Type (2021-2032) Figure 55. South America, Middle East & Africa Rheumatoid Arthritis Stem Cell Therapy Market Share by Application (2021-2032) Figure 56. South America, Middle East & Africa Rheumatoid Arthritis Stem Cell Therapy Market Share by Country (2021-2032) Figure 57. Brazil Rheumatoid Arthritis Stem Cell Therapy Market Size (2021-2032) & (US$ Million) Figure 58. South Africa Rheumatoid Arthritis Stem Cell Therapy Market Size (2021-2032) & (US$ Million) Figure 59. Saudi Arabia Rheumatoid Arthritis Stem Cell Therapy Market Size (2021-2032) & (US$ Million) Figure 60. Turkey Rheumatoid Arthritis Stem Cell Therapy Market Size (2021-2032) & (US$ Million) Figure 61. Argentina Rheumatoid Arthritis Stem Cell Therapy Market Size (2021-2032) & (US$ Million) Figure 62. UAE Rheumatoid Arthritis Stem Cell Therapy Market Size (2021-2032) & (US$ Million) Figure 63. Egypt Rheumatoid Arthritis Stem Cell Therapy Market Size (2021-2032) & (US$ Million) Figure 64. Chile Rheumatoid Arthritis Stem Cell Therapy Market Size (2021-2032) & (US$ Million) Figure 65. Research Process Figure 66. Key Executives Interviewed

Scope & coverage.

Types
  • Adipose Tissue Stem Cells
  • Allogeneic Mesenchymal Stem Cells
  • Bone Marrow Transplant
Applications
  • Ambulatory Surgical Centers
  • Hospitals
  • Specialty Clinics
Companies covered
  • International Stem Cell Corporation
  • Mesoblast
  • Regeneus
  • ReNeuron Group
  • Roslin Cells
  • Takeda

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Rheumatoid Arthritis Stem Cell Therapy Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Adipose Tissue Stem Cells
  5. 1.2.3 Allogeneic Mesenchymal Stem Cells
  6. 1.2.4 Bone Marrow Transplant
  7. 1.3 Market Analysis by Application
  8. 1.3.1 Global Rheumatoid Arthritis Stem Cell Therapy Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  9. 1.3.2 Ambulatory Surgical Centers
  10. 1.3.3 Hospitals
  11. 1.3.4 Specialty Clinics
  12. 1.4 Global Market Growth Prospects
  13. 1.5 Global Rheumatoid Arthritis Stem Cell Therapy Growth Trends by Region
  14. 1.5.1 Global Rheumatoid Arthritis Stem Cell Therapy Market Size by Region: 2021 VS 2025 VS 2032
  15. 1.5.2 Rheumatoid Arthritis Stem Cell Therapy Market Size by Region (2021-2026)
  16. 1.5.3 Rheumatoid Arthritis Stem Cell Therapy Market Size by Region (2027-2032)
  17. 1.6 Assumptions and Limitations
  18. 1.7 Study Goals and Objectives
  19. 1.8 Years Considered
2 Global Rheumatoid Arthritis Stem Cell Therapy Market Dynamics
  1. 2.1 Rheumatoid Arthritis Stem Cell Therapy Industry Trends
  2. 2.2 Rheumatoid Arthritis Stem Cell Therapy Industry Drivers
  3. 2.3 Rheumatoid Arthritis Stem Cell Therapy Industry Opportunities and Challenges
  4. 2.4 Rheumatoid Arthritis Stem Cell Therapy Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Rheumatoid Arthritis Stem Cell Therapy Revenue by Company (2021-2026)
  2. 3.2 Global Rheumatoid Arthritis Stem Cell Therapy Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Rheumatoid Arthritis Stem Cell Therapy Key Company Head office and Area Served
  4. 3.4 Global Rheumatoid Arthritis Stem Cell Therapy Company, Product Type & Application
  5. 3.5 Global Rheumatoid Arthritis Stem Cell Therapy Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Rheumatoid Arthritis Stem Cell Therapy Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Rheumatoid Arthritis Stem Cell Therapy Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Rheumatoid Arthritis Stem Cell Therapy Tier 1, Tier 2, and Tier 3
4 Rheumatoid Arthritis Stem Cell Therapy Market by Type
  1. 4.1 Global Rheumatoid Arthritis Stem Cell Therapy Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Rheumatoid Arthritis Stem Cell Therapy Market Size by Type (2021-2032)
  3. 4.3 Global Rheumatoid Arthritis Stem Cell Therapy Market Size Share by Type (2021-2032)
5 Rheumatoid Arthritis Stem Cell Therapy Market by Application
  1. 5.1 Global Rheumatoid Arthritis Stem Cell Therapy Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Rheumatoid Arthritis Stem Cell Therapy Market Size by Application (2021-2032)
  3. 5.3 Global Rheumatoid Arthritis Stem Cell Therapy Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 International Stem Cell Corporation
  2. 6.1.1 International Stem Cell Corporation Company Information
  3. 6.1.2 International Stem Cell Corporation Business Overview
  4. 6.1.3 International Stem Cell Corporation Rheumatoid Arthritis Stem Cell Therapy Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 International Stem Cell Corporation Rheumatoid Arthritis Stem Cell Therapy Product Portfolio
  6. 6.1.5 International Stem Cell Corporation Recent Developments
  7. 6.2 Mesoblast
  8. 6.2.1 Mesoblast Company Information
  9. 6.2.2 Mesoblast Business Overview
  10. 6.2.3 Mesoblast Rheumatoid Arthritis Stem Cell Therapy Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Mesoblast Rheumatoid Arthritis Stem Cell Therapy Product Portfolio
  12. 6.2.5 Mesoblast Recent Developments
  13. 6.3 Regeneus
  14. 6.3.1 Regeneus Company Information
  15. 6.3.2 Regeneus Business Overview
  16. 6.3.3 Regeneus Rheumatoid Arthritis Stem Cell Therapy Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Regeneus Rheumatoid Arthritis Stem Cell Therapy Product Portfolio
  18. 6.3.5 Regeneus Recent Developments
  19. 6.4 ReNeuron Group
  20. 6.4.1 ReNeuron Group Company Information
  21. 6.4.2 ReNeuron Group Business Overview
  22. 6.4.3 ReNeuron Group Rheumatoid Arthritis Stem Cell Therapy Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 ReNeuron Group Rheumatoid Arthritis Stem Cell Therapy Product Portfolio
  24. 6.4.5 ReNeuron Group Recent Developments
  25. 6.5 Roslin Cells
  26. 6.5.1 Roslin Cells Company Information
  27. 6.5.2 Roslin Cells Business Overview
  28. 6.5.3 Roslin Cells Rheumatoid Arthritis Stem Cell Therapy Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Roslin Cells Rheumatoid Arthritis Stem Cell Therapy Product Portfolio
  30. 6.5.5 Roslin Cells Recent Developments
  31. 6.6 Takeda
  32. 6.6.1 Takeda Company Information
  33. 6.6.2 Takeda Business Overview
  34. 6.6.3 Takeda Rheumatoid Arthritis Stem Cell Therapy Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 Takeda Rheumatoid Arthritis Stem Cell Therapy Product Portfolio
  36. 6.6.5 Takeda Recent Developments
7 North America
  1. 7.1 North America Rheumatoid Arthritis Stem Cell Therapy Market Size (2021-2032)
  2. 7.2 North America Rheumatoid Arthritis Stem Cell Therapy Market Size by Type
  3. 7.2.1 North America Rheumatoid Arthritis Stem Cell Therapy Market Size by Type (2021-2026)
  4. 7.2.2 North America Rheumatoid Arthritis Stem Cell Therapy Market Size by Type (2027-2032)
  5. 7.2.3 North America Rheumatoid Arthritis Stem Cell Therapy Market Share by Type (2021-2032)
  6. 7.3 North America Rheumatoid Arthritis Stem Cell Therapy Market Size by Application
  7. 7.3.1 North America Rheumatoid Arthritis Stem Cell Therapy Market Size by Application (2021-2026)
  8. 7.3.2 North America Rheumatoid Arthritis Stem Cell Therapy Market Size by Application (2027-2032)
  9. 7.3.3 North America Rheumatoid Arthritis Stem Cell Therapy Market Share by Application (2021-2032)
  10. 7.4 North America Rheumatoid Arthritis Stem Cell Therapy Market Size by Country
  11. 7.4.1 North America Rheumatoid Arthritis Stem Cell Therapy Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Rheumatoid Arthritis Stem Cell Therapy Market Size by Country (2021-2026)
  13. 7.4.3 North America Rheumatoid Arthritis Stem Cell Therapy Market Size by Country (2027-2032)
  14. 7.4.4 North America Rheumatoid Arthritis Stem Cell Therapy Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Rheumatoid Arthritis Stem Cell Therapy Market Size (2021-2032)
  2. 8.2 Europe Rheumatoid Arthritis Stem Cell Therapy Market Size by Type
  3. 8.2.1 Europe Rheumatoid Arthritis Stem Cell Therapy Market Size by Type (2021-2026)
  4. 8.2.2 Europe Rheumatoid Arthritis Stem Cell Therapy Market Size by Type (2027-2032)
  5. 8.2.3 Europe Rheumatoid Arthritis Stem Cell Therapy Market Share by Type (2021-2032)
  6. 8.3 Europe Rheumatoid Arthritis Stem Cell Therapy Market Size by Application
  7. 8.3.1 Europe Rheumatoid Arthritis Stem Cell Therapy Market Size by Application (2021-2026)
  8. 8.3.2 Europe Rheumatoid Arthritis Stem Cell Therapy Market Size by Application (2027-2032)
  9. 8.3.3 Europe Rheumatoid Arthritis Stem Cell Therapy Market Share by Application (2021-2032)
  10. 8.4 Europe Rheumatoid Arthritis Stem Cell Therapy Market Size by Country
  11. 8.4.1 Europe Rheumatoid Arthritis Stem Cell Therapy Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Rheumatoid Arthritis Stem Cell Therapy Market Size by Country (2021-2026)
  13. 8.4.3 Europe Rheumatoid Arthritis Stem Cell Therapy Market Size by Country (2027-2032)
  14. 8.4.4 Europe Rheumatoid Arthritis Stem Cell Therapy Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Rheumatoid Arthritis Stem Cell Therapy Market Size (2021-2032)
  2. 9.2 China Rheumatoid Arthritis Stem Cell Therapy Market Size by Type
  3. 9.2.1 China Rheumatoid Arthritis Stem Cell Therapy Market Size by Type (2021-2026)
  4. 9.2.2 China Rheumatoid Arthritis Stem Cell Therapy Market Size by Type (2027-2032)
  5. 9.2.3 China Rheumatoid Arthritis Stem Cell Therapy Market Share by Type (2021-2032)
  6. 9.3 China Rheumatoid Arthritis Stem Cell Therapy Market Size by Application
  7. 9.3.1 China Rheumatoid Arthritis Stem Cell Therapy Market Size by Application (2021-2026)
  8. 9.3.2 China Rheumatoid Arthritis Stem Cell Therapy Market Size by Application (2027-2032)
  9. 9.3.3 China Rheumatoid Arthritis Stem Cell Therapy Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Rheumatoid Arthritis Stem Cell Therapy Market Size (2021-2032)
  2. 10.2 Asia Rheumatoid Arthritis Stem Cell Therapy Market Size by Type
  3. 10.2.1 Asia Rheumatoid Arthritis Stem Cell Therapy Market Size by Type (2021-2026)
  4. 10.2.2 Asia Rheumatoid Arthritis Stem Cell Therapy Market Size by Type (2027-2032)
  5. 10.2.3 Asia Rheumatoid Arthritis Stem Cell Therapy Market Share by Type (2021-2032)
  6. 10.3 Asia Rheumatoid Arthritis Stem Cell Therapy Market Size by Application
  7. 10.3.1 Asia Rheumatoid Arthritis Stem Cell Therapy Market Size by Application (2021-2026)
  8. 10.3.2 Asia Rheumatoid Arthritis Stem Cell Therapy Market Size by Application (2027-2032)
  9. 10.3.3 Asia Rheumatoid Arthritis Stem Cell Therapy Market Share by Application (2021-2032)
  10. 10.4 Asia Rheumatoid Arthritis Stem Cell Therapy Market Size by Country
  11. 10.4.1 Asia Rheumatoid Arthritis Stem Cell Therapy Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Rheumatoid Arthritis Stem Cell Therapy Market Size by Country (2021-2026)
  13. 10.4.3 Asia Rheumatoid Arthritis Stem Cell Therapy Market Size by Country (2027-2032)
  14. 10.4.4 Asia Rheumatoid Arthritis Stem Cell Therapy Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Rheumatoid Arthritis Stem Cell Therapy Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Rheumatoid Arthritis Stem Cell Therapy Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Rheumatoid Arthritis Stem Cell Therapy Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Rheumatoid Arthritis Stem Cell Therapy Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Rheumatoid Arthritis Stem Cell Therapy Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Rheumatoid Arthritis Stem Cell Therapy Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Rheumatoid Arthritis Stem Cell Therapy Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Rheumatoid Arthritis Stem Cell Therapy Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Rheumatoid Arthritis Stem Cell Therapy Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Rheumatoid Arthritis Stem Cell Therapy Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Rheumatoid Arthritis Stem Cell Therapy Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Rheumatoid Arthritis Stem Cell Therapy Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Rheumatoid Arthritis Stem Cell Therapy Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Rheumatoid Arthritis Stem Cell Therapy Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst